Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Clinical Study to Assess the Efficacy and Safety of Sovateltide in Patients With Traumatic Brain Injury

NCT07861126 is registered in ClinicalTrials.gov with Pharmazz, Inc. as lead sponsor.

NCT NCT07861126
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07861126 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Clinical Study to Assess the Efficacy and Safety of Sovateltide in Patients With Traumatic Brain Injury
Lead sponsor
Pharmazz, Inc.
Phase
Phase 3
Overall status
Not yet recruiting
Start date
December 31, 2026
Completion date
March 31, 2028
Enrollment
214 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

traumatic brain injury